MyFinsight
Home
Blog
About
Back
Income Statement
Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc. (DNLI)
source: myfinsight.com
Comprehensive loss
-$128,840K
(-2.89%↓ Y/Y)
Net loss
-$127,553K
(-2.77%↓ Y/Y)
Net unrealized gain
on marketable...
-$1,287K
(-17.21%↓ Y/Y)
Interest and other
income, net
$2,988K
(-72.45%↓ Y/Y)
Loss from operations
-$130,541K
(3.28%↑ Y/Y)
Total revenue
$3,604K
Total operating
expenses
$134,145K
(-0.61%↓ Y/Y)
Research and development
$97,019K
(-5.53%↓ Y/Y)
Selling, general and
administrative
$36,283K
Intangible asset
amortization
$750K
Cost of goods sold
$93K
Back